Developer · 002262.SZ · China
Jiangsu Nhwa Pharmaceutical Co., Ltd.
CNS-focused pharmaceutical company based in Xuzhou, Jiangsu, China, listed on the Shenzhen Stock Exchange (002262, 恩华药业). Develops and markets anaesthesia, analgesia and psychiatric/neurological drugs, and reports 20+ innovative drug projects in development, including NH102 (depression, Phase 2 completed), NHL35700 (schizophrenia, Phase 3), NH130 (Parkinson's disease psychosis) and the YH1910 programs in depression.
Pipeline (1)
- Major depressive disorderPhase 2Completed
Catalysts · 0 upcoming · 1 reported
Recently reported
- 2026-10-11met
NH102forMajor depressive disorderFull results
Phase 2 proof-of-concept in MDD: NH102 30 mg beat placebo on HAMD-17 at week 6 (difference -2.8, P=0.036); lower doses not significant; not different from duloxetine.
Recent activity
- Oct 11, 2026ReadoutNH102·Major depressive disordermetPhase 2 proof-of-concept in MDD: NH102 30 mg beat placebo on HAMD-17 at week 6 (difference -2.8, P=0.036); lower doses not significant; not different from duloxetine.source ↗
- Sep 12, 2025Phase changeNH102·Major depressive disorderPhase 2NCT06842992 completed (primary completion 2025-07-30, study completion 2025-09-12). Nhwa's 2026 interim report lists NH102 tablet among projects that have completed Phase II.source ↗
- Dec 4, 2024Phase changeNH102·Major depressive disorderPhase 2Phase 2 dose-finding trial NCT06842992 (NH102-21) in major depressive disorder started; 243 enrolled.source ↗
Competitive landscape
Other companies developing against Jiangsu Nhwa Pharmaceutical Co., Ltd.'s targets or indications.
- Definium Therapeutics, Inc.2 compoundsSERTMajor depressive disorder
- Otsuka Pharmaceutical Co., Ltd.2 compoundsSERTMajor depressive disorder
- ABVC BioPharma, Inc.1 compoundMajor depressive disorder
- Alto Neuroscience, Inc.2 compoundsMajor depressive disorder
- Autobahn Therapeutics, Inc.1 compoundMajor depressive disorder
- Axsome Therapeutics, Inc.1 compoundMajor depressive disorder
- Beckley Psytech Limited1 compoundMajor depressive disorder
- Biohaven Ltd.1 compoundMajor depressive disorder
- Boehringer Ingelheim2 compoundsMajor depressive disorder
- Cerevel Therapeutics1 compoundMajor depressive disorder
- COMPASS Pathways plc1 compoundMajor depressive disorder
- CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.1 compoundMajor depressive disorder